Pin1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Pin1 monoclonal antibodies for research focused on understanding Pin1 protein functions. Pin1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pin1, or Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, plays a critical role in regulating protein function and cellular signaling by catalyzing the isomerization of proline residues in target proteins. This post-translational modification is essential for various cellular processes, including cell cycle progression, apoptosis, and stress response. Dysregulation of Pin1 has been implicated in several diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic research. Pin1 monoclonal antibodies enable detailed investigation of molecular pathways and cellular mechanisms. Pin1 research continues to reveal new insights into disease progression and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Pin1's role in health and disease.